Epirubicin extends disease-free survival in tamoxifen recipients

Author：  

Publisher： Adis International

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1470, 2005-01, pp. : 16-16

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

CAF chemotherapy extends survival with tamoxifen

By  

Inpharma, Vol. 1, Iss. 1474, 2005-01 ,pp. : 13-14

Adis International

Access to resources Recommend Favorite

Switching to adjuvant exemestane after tamoxifen improves disease-free survival in postmenopausal women with hormone receptor-positive early breast cancer

By Adis International Limited  

Drugs & Therapy Perspectives, Vol. 23, Iss. 5, 2007-05 ,pp. : 1-4

Adis International

Access to resources Recommend Favorite

Sipuleucel-T extends survival in metastatic prostate cancer

By  

Inpharma, Vol. 1, Iss. 1546, 2006-01 ,pp. : 6-6

Adis International

Access to resources Recommend Favorite

Cetuximab extends survival in patients with mCRC

By  

Inpharma, Vol. 1, Iss. 1657, 2008-01 ,pp. : 14-14

Adis International

Access to resources Recommend Favorite

L-BLP25 vaccine extends survival in NSCLC

By  

Inpharma, Vol. 1, Iss. 1470, 2005-01 ,pp. : 7-8

Adis International

Access to resources Recommend Favorite